CompletedNot applicableNCT06168825

Mind Over Matter for Black and African American Women: A Single Arm Trial Examining Feasibility and Acceptability of a Supportive Intervention

The goal of this study is to learn if the Mind Over Matter (MOM) Intervention, a 5-week group program, can help Black and African American women deal with the fears, worries and sadness that often accompany cancer diagnosis and treatment. The main question this study aims to answer is: • Whether the MOM Intervention is feasible and acceptable among Black and African American women. We would also like to find out if: * The MOM Intervention decreases anxiety, depression and physical symptom severity for Black and African American women. * The MOM Intervention is culturally and linguistically appropriate, and identify barriers, strengths, and areas of improvement. Participants will: * Attend a Pre-Program Orientation * Attend 5 weekly MOM Sessions * Complete 2 questionnaires (one will be given before the first MOM Session begins, and the other will be given after the last MOM Session) Participants also have the choice to attend an optional Focus Group, which will be offered after the last MOM Session. Please note, this entire Intervention will be offered online. There will be no in-person sessions or visits.

Checked against the public recordLast updated Feb 27, 2025 · Source: ClinicalTrials.gov

StatusCompleted
PhaseNot applicable
U.S. locations2
SponsorInova Health Care Services
01
Study overview

What this study is about

Purpose
Not specified
Study type
Observational
Phase
Not applicable
Sponsor
Inova Health Care Services
Interventions being studied
Other: Mind Over Matter (MOM)
02
Explore related studies

How this study is categorized

These labels come from structured fields and exact terms in the public record.

03
Public criteria

Who may be able to participate

Inclusion Criteria: * Self-identify as Black or African American * Self-identify as female or a woman * Having received a diagnosis and treatment for any type of cancer * Having completed primary treatment (completed chemotherapy and/or radiation and/or surgery) * ≥18 years of age * Able to understand and provide valid informed consent prior to any study procedure * Access to the internet and email * Being able to speak and understand written and spoken English Exclusion Criteria: * Self-identify as other than Black or African American * Does not Self-identify as a female or a woman * Does not have a diagnosis of cancer * Has not completed primary treatment * Under the age of 18 * Not able to understand and provide valid informed consent * Does not have access to the internet or email * Not being able to speak, read and understand English

Important: This is the sponsor’s public criteria, not a determination of eligibility. The study team must review your individual situation.

04
Study sites

U.S. locations

  • Howard University Cancer CenterWashington D.C., District of Columbia
  • Inova Life With CancerFairfax, Virginia

Source and freshness
Processed from ClinicalTrials.gov. Last public update: Feb 27, 2025. Always confirm current availability with the study team.

View original record ↗